Shuttle Pharmaceuticals Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Shuttle Pharmaceuticals Holdings generated cash of -$5,581,147, which is less than the previous year. Cash used in financing activities reached the amount of $2,570,083 last year. Net change in cash is therefore -$5,840,787.
Cash Flow
| 2017 | -202.70K | 0 | 160.61K |
|---|---|---|---|
| 2020 | -26.83K | -10.81K | 70.07K |
| 2021 | -300.33K | 0 | 687.93K |
| 2022 | -2.71M | 0 | 10.62M |
| 2023 | -5.58M | -2.82M | 2.57M |
SHPH Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2017 | |
|---|---|---|---|---|---|
Cash at beginning of period | 8.41M | 504.74K | 117.15K | 84.72K | 92.79K |
Operating activities | |||||
Net income | -6.59M | -3.02M | -1.15M | -805.73K | -213.59K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 6.81K | 66.83K | 60.83K | 54.95K | 18.73K |
Stock-based compensation expense | 181.96K | 403.95K | 910.06K | 459.58K | 0 |
| Deferred income tax benefit | 181.96K | 403.95K | 910.06K | 459.58K | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 211.45K | 164.92K | -30.43K |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 154.06K | -382.88K | 311.34K | -51.12K | 10.57K |
Cash generated by operating activities | -5.58M | -2.71M | -300.33K | -26.83K | -202.70K |
Investing activities | |||||
Purchases Of Investments | -2.99M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -19.04K | 0 | 0 | -10.81K | 0 |
Acquisitions Net | 3.01M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -2.82M | 0 | 0 | -10.81K | 0 |
Financing activities | |||||
Common Stock Issued | 2.69M | 9.99M | 0 | 0 | 100 |
Payments for dividends | 0 | -402.06K | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 2.91M | 600.71K | -687.93K | -70.07K | 160.51K |
Cash used in financing activities | 2.57M | 10.62M | 687.93K | 70.07K | 160.61K |
Net Change In Cash | -5.84M | 7.91M | 387.59K | 32.42K | -42.08K |
Cash at end of period | 2.57M | 8.41M | 504.74K | 117.15K | 50.70K |
| Data source | Data source |